Displaying 25 - 36 of 59
Metabolism, Alcohol & Toxicity
6

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence - EASL SLD Summit 2025

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease - EASL SLD Summit 2025

View
Metabolism, Alcohol & Toxicity
5

Novo Nordisk: Addressing MASH as a liver manifestation of the metabolic disease - EASL SLD Summit 2025

View
Metabolism, Alcohol & Toxicity
1

Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
1

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
6

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
8

Sanofi: "Global Liver Health Forum 2023" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
8

Sanofi: "Global Liver Health Forum 2023" - EASL Congress 2023

View
Displaying 25 - 36 of 59